LYEL: Lyell Immunopharma, Inc. Stock

by  •  • Comments Off on LYEL: Lyell Immunopharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 611.85
Enterprise Value ($M) 466.20
Book Value ($M) 654.95
Book Value / Share 2.57
Price / Book 0.93
NCAV ($M) 459.61
NCAV / Share 1.80
Price / NCAV 1.33

Profitability (mra)
Return on Invested Capital (ROIC) -0.33
Return on Assets (ROA) -0.27
Return on Equity (ROE) -0.30

Liquidity (mrq)
Quick Ratio 16.07
Current Ratio 16.07

Balance Sheet (mrq) ($M)
Current Assets 554.69
Assets 750.03
Liabilities 95.08
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.13
Operating Income -245.50
Net Income -234.63

Cash Flow Statement (mra) ($M)
Cash From Operations -163.69
Cash from Investing 184.05
Cash from Financing 1.74

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A ARCH Venture Fund IX, L.P. 14.50 0.18
02-13 13G/A Vanguard Group Inc 5.40 8.04
01-29 13G BlackRock Inc. 5.70

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2023-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-03 94,293 379,915 24.82
2024-05-02 270,395 296,374 91.23
2024-05-01 222,255 313,017 71.00
2024-04-30 111,119 249,597 44.52
2024-04-29 49,927 133,370 37.43

(click for more detail)

Similar Companies
KZR – Kezar Life Sciences, Inc. LVTX – LAVA Therapeutics N.V.
LXRX – Lexicon Pharmaceuticals, Inc. MCRB – Seres Therapeutics, Inc.
MDGL – Madrigal Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io